Logo image of NEXT.OL

NEXT BIOMETRICS GROUP AS (NEXT.OL) Stock Fundamental Analysis

Europe - OSL:NEXT - NO0010629108 - Common Stock

3.36 NOK
+0.07 (+2.13%)
Last: 10/31/2025, 7:00:00 PM
Fundamental Rating

2

Overall NEXT gets a fundamental rating of 2 out of 10. We evaluated NEXT against 53 industry peers in the Electronic Equipment, Instruments & Components industry. While NEXT seems to be doing ok healthwise, there are quite some concerns on its profitability. NEXT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NEXT has reported negative net income.
In the past year NEXT has reported a negative cash flow from operations.
In the past 5 years NEXT always reported negative net income.
In the past 5 years NEXT always reported negative operating cash flow.
NEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFNEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

NEXT has a Return On Assets of -68.81%. This is amonst the worse of the industry: NEXT underperforms 90.57% of its industry peers.
With a Return On Equity value of -90.13%, NEXT is not doing good in the industry: 86.79% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -68.81%
ROE -90.13%
ROIC N/A
ROA(3y)-41%
ROA(5y)-47.51%
ROE(3y)-52%
ROE(5y)-61.09%
ROIC(3y)N/A
ROIC(5y)N/A
NEXT.OL Yearly ROA, ROE, ROICNEXT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100

1.3 Margins

NEXT has a Gross Margin of 47.55%. This is in the better half of the industry: NEXT outperforms 66.04% of its industry peers.
In the last couple of years the Gross Margin of NEXT has grown nicely.
NEXT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y45.73%
GM growth 5Y17.56%
NEXT.OL Yearly Profit, Operating, Gross MarginsNEXT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

6

2. Health

2.1 Basic Checks

NEXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
NEXT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NEXT has more shares outstanding
NEXT has a worse debt/assets ratio than last year.
NEXT.OL Yearly Shares OutstandingNEXT.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NEXT.OL Yearly Total Debt VS Total AssetsNEXT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 8.72 indicates that NEXT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.72, NEXT belongs to the top of the industry, outperforming 90.57% of the companies in the same industry.
NEXT has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
NEXT has a better Debt to Equity ratio (0.02) than 90.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 8.72
ROIC/WACCN/A
WACC8.53%
NEXT.OL Yearly LT Debt VS Equity VS FCFNEXT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

2.3 Liquidity

NEXT has a Current Ratio of 4.21. This indicates that NEXT is financially healthy and has no problem in meeting its short term obligations.
NEXT's Current ratio of 4.21 is amongst the best of the industry. NEXT outperforms 90.57% of its industry peers.
NEXT has a Quick Ratio of 3.27. This indicates that NEXT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of NEXT (3.27) is better than 94.34% of its industry peers.
Industry RankSector Rank
Current Ratio 4.21
Quick Ratio 3.27
NEXT.OL Yearly Current Assets VS Current LiabilitesNEXT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

NEXT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.26%.
NEXT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.10%.
The Revenue has been decreasing by -3.25% on average over the past years.
EPS 1Y (TTM)4.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.33%
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y12.14%
Revenue growth 5Y-3.25%
Sales Q2Q%-111.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NEXT.OL Yearly Revenue VS EstimatesNEXT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NEXT.OL Yearly EPS VS EstimatesNEXT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NEXT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEXT.OL Price Earnings VS Forward Price EarningsNEXT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEXT.OL Per share dataNEXT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NEXT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXT BIOMETRICS GROUP AS

OSL:NEXT (10/31/2025, 7:00:00 PM)

3.36

+0.07 (+2.13%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-20 2025-08-20
Earnings (Next)11-05 2025-11-05
Inst Owners11.18%
Inst Owner ChangeN/A
Ins Owners7.42%
Ins Owner ChangeN/A
Market Cap402.73M
Revenue(TTM)45.17M
Net Income(TTM)-61248000
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.92
P/FCF N/A
P/OCF N/A
P/B 5.93
P/tB 6.06
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS0.38
BVpS0.57
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -68.81%
ROE -90.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.55%
FCFM N/A
ROA(3y)-41%
ROA(5y)-47.51%
ROE(3y)-52%
ROE(5y)-61.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y45.73%
GM growth 5Y17.56%
F-Score2
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 35.44%
Cap/Sales 3.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.21
Quick Ratio 3.27
Altman-Z 8.72
F-Score2
WACC8.53%
ROIC/WACCN/A
Cap/Depr(3y)4.07%
Cap/Depr(5y)3.14%
Cap/Sales(3y)0.34%
Cap/Sales(5y)0.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y12.14%
Revenue growth 5Y-3.25%
Sales Q2Q%-111.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-74.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.36%
OCF growth 3YN/A
OCF growth 5YN/A

NEXT BIOMETRICS GROUP AS / NEXT.OL FAQ

What is the ChartMill fundamental rating of NEXT BIOMETRICS GROUP AS (NEXT.OL) stock?

ChartMill assigns a fundamental rating of 2 / 10 to NEXT.OL.


What is the valuation status for NEXT stock?

ChartMill assigns a valuation rating of 0 / 10 to NEXT BIOMETRICS GROUP AS (NEXT.OL). This can be considered as Overvalued.


How profitable is NEXT BIOMETRICS GROUP AS (NEXT.OL) stock?

NEXT BIOMETRICS GROUP AS (NEXT.OL) has a profitability rating of 1 / 10.


What is the financial health of NEXT BIOMETRICS GROUP AS (NEXT.OL) stock?

The financial health rating of NEXT BIOMETRICS GROUP AS (NEXT.OL) is 6 / 10.